ENHYPEN Knife plagiarism controversy 2026: A Clash of Identities at HYBE
Dive into the ENHYPEN Knife plagiarism controversy 2026. Explore the heated debate between fans and critics over HYBE's musical identity and the new track.
Is K-Pop losing its creative edge? ENHYPEN just dropped their latest album THE SIN: VANISH, but the celebration was short-lived. The title track Knife has sparked an intense online debate, with some listeners accusing the group of mimicking the sound of their labelmates.
CORTIS Comparison Sparks Outcry
Shortly after the release, netizens pointed out striking similarities between Knife and the musical style of CORTIS, a new group under BIGHIT MUSIC. Since both BELIFT LAB and BIGHIT operate under the HYBE umbrella, critics argue that the conglomerate is recycling sounds rather than fostering individual identities. One viral post on X claimed that "HYBE artists have no unique identity anymore."
Fanbase Defends ENHYPEN’s Originality
However, the ENGENE fandom isn't staying silent. Fans highlighted that ENHYPEN has been building this specific sound for years, citing tracks like Pass the Mic. Rumors have also surfaced that ENHYPEN received the demo for Knife at least 3 months before CORTIS even debuted in 2026. This timeline, if true, would debunk the plagiarism claims, suggesting that any similarity is a result of shared production trends within the multi-label system.
This content is AI-generated based on source articles. While we strive for accuracy, errors may occur. We recommend verifying with the original source.
Related Articles
BIGHIT MUSIC's rookie boy group CORTIS announces April comeback with pre-release strategy, testing new waters in the saturated K-pop market.
CORTIS becomes only the second K-pop group to sell 2 million copies of their debut album, marking a new milestone in the industry's evolution.
From ENHYPEN to TWICE, the latest Circle Chart rankings reveal shifting trends in K-pop consumption and the evolving nature of global fandoms.
KATSEYE member Manon announces temporary hiatus for health reasons, highlighting the challenges facing multinational K-Pop groups in HYBE's global expansion strategy.
Thoughts
Share your thoughts on this article
Sign in to join the conversation